Brazil · Delayed Price · Currency is BRL Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of BRL 41.20 billion. The enterprise value is 49.52 billion.
| Market Cap | 41.20B |
| Enterprise Value | 49.52B |
Important Dates
The last earnings date was Tuesday, March 3, 2026.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | Dec 8, 2025 |
Share Statistics
Raia Drogasil has 1.75 billion shares outstanding. The number of shares has decreased by -1.75% in one year.
| Current Share Class | 1.75B |
| Shares Outstanding | 1.75B |
| Shares Change (YoY) | -1.75% |
| Shares Change (QoQ) | -8.35% |
| Owned by Insiders (%) | 18.98% |
| Owned by Institutions (%) | 49.03% |
| Float | 1.31B |
Valuation Ratios
The trailing PE ratio is 30.16 and the forward PE ratio is 23.06. Raia Drogasil's PEG ratio is 1.10.
| PE Ratio | 30.16 |
| Forward PE | 23.06 |
| PS Ratio | 0.93 |
| PB Ratio | 5.62 |
| P/TBV Ratio | 7.82 |
| P/FCF Ratio | 40.09 |
| P/OCF Ratio | 16.95 |
| PEG Ratio | 1.10 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.88, with an EV/FCF ratio of 48.19.
| EV / Earnings | 38.18 |
| EV / Sales | 1.12 |
| EV / EBITDA | 10.88 |
| EV / EBIT | 18.50 |
| EV / FCF | 48.19 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.20.
| Current Ratio | 1.46 |
| Quick Ratio | 0.45 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | 1.94 |
| Debt / FCF | 8.60 |
| Interest Coverage | 2.49 |
Financial Efficiency
Return on equity (ROE) is 18.87% and return on invested capital (ROIC) is 15.88%.
| Return on Equity (ROE) | 18.87% |
| Return on Assets (ROA) | 7.06% |
| Return on Invested Capital (ROIC) | 15.88% |
| Return on Capital Employed (ROCE) | 17.86% |
| Weighted Average Cost of Capital (WACC) | 6.15% |
| Revenue Per Employee | 598,829 |
| Profits Per Employee | 17,550 |
| Employee Count | 73,895 |
| Asset Turnover | 1.87 |
| Inventory Turnover | 3.48 |
Taxes
In the past 12 months, Raia Drogasil has paid 147.81 million in taxes.
| Income Tax | 147.81M |
| Effective Tax Rate | 10.21% |
Stock Price Statistics
The stock price has increased by +29.45% in the last 52 weeks. The beta is 0.16, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +29.45% |
| 50-Day Moving Average | 24.94 |
| 200-Day Moving Average | 19.64 |
| Relative Strength Index (RSI) | 37.54 |
| Average Volume (20 Days) | 10,196,760 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of BRL 44.25 billion and earned 1.30 billion in profits. Earnings per share was 0.78.
| Revenue | 44.25B |
| Gross Profit | 12.96B |
| Operating Income | 2.68B |
| Pretax Income | 1.45B |
| Net Income | 1.30B |
| EBITDA | 3.52B |
| EBIT | 2.68B |
| Earnings Per Share (EPS) | 0.78 |
Balance Sheet
The company has 528.74 million in cash and 8.83 billion in debt, with a net cash position of -8.31 billion or -4.75 per share.
| Cash & Cash Equivalents | 528.74M |
| Total Debt | 8.83B |
| Net Cash | -8.31B |
| Net Cash Per Share | -4.75 |
| Equity (Book Value) | 7.34B |
| Book Value Per Share | 4.19 |
| Working Capital | 4.71B |
Cash Flow
In the last 12 months, operating cash flow was 2.43 billion and capital expenditures -1.40 billion, giving a free cash flow of 1.03 billion.
| Operating Cash Flow | 2.43B |
| Capital Expenditures | -1.40B |
| Free Cash Flow | 1.03B |
| FCF Per Share | 0.59 |
Margins
Gross margin is 29.30%, with operating and profit margins of 6.05% and 2.93%.
| Gross Margin | 29.30% |
| Operating Margin | 6.05% |
| Pretax Margin | 3.27% |
| Profit Margin | 2.93% |
| EBITDA Margin | 7.96% |
| EBIT Margin | 6.05% |
| FCF Margin | 2.32% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.26%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 1.26% |
| Dividend Growth (YoY) | 32.97% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 56.36% |
| Buyback Yield | 1.75% |
| Shareholder Yield | 3.02% |
| Earnings Yield | 3.15% |
| FCF Yield | 2.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 23, 2025. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 23, 2025 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Raia Drogasil has an Altman Z-Score of 3.54 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.54 |
| Piotroski F-Score | 6 |